You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Spacers were better and less expensive than nebulisers for giving albuterol to children with moderate to severe acute asthma

Article Text

Article menu
Download PDFPDF
Economics
Spacers were better and less expensive than nebulisers for giving albuterol to children with moderate to severe acute asthma

https://doi.org/10.1136/ebm.6.1.31

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (2000) J Pediatr 136, 497. Leversha AM, Campanella SG, Aickin RP. , et al. . Costs and effectiveness of spacer versus nebulizer in young children with moderate and severe acute asthma.. Apr;. :. –502.
    OpenUrlCrossRefPubMedWeb of Science

    
 
 QUESTION: In young children seen in the emergency department for moderate and severe acute asthma, is delivery of albuterol by metered dose inhaler (MDI) and spacer a cost effective alternative to delivery by nebuliser?

    Design

    Randomised (allocation concealed*), blinded {patients, clinicians, and outcome assessors}†,* controlled trial with 48 hour follow up.

    Setting

    A children's hospital in Auckland, New Zealand.

    Patients

    60 children who were 1 to 4 years of age (mean age 34 mo, 64% boys), had a known history of asthma, and presented to the emergency department with an acute exacerbation of asthma that was rated as moderate to severe. Exclusion criteria were inhaled bronchodilator use in the hour before presentation, immediate admission to the intensive care unit, or a co-existing medical condition, such as pneumonia. Follow up was complete.

    Intervention

    Children were allocated to albuterol, 600 μg by …

    View Full Text